Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,968 | -19,270 | -4,539 | -2,120 | N/A |
| Depreciation Amortization | 156 | 17 | 1 | N/A | N/A |
| Other Working Capital | 2,569 | 2,662 | 736 | 155 | N/A |
| Other Operating Activity | 3,142 | 3,082 | 1,606 | 671 | 0 |
| Operating Cash Flow | $-27,101 | $-13,509 | $-2,196 | $-1,294 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -870 | -340 | N/A | -4 | N/A |
| Investing Cash Flow | $-870 | $-340 | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,832 | 56,520 | 2,061 | N/A | N/A |
| Other Financing Activity | 0 | -993 | 1,022 | 1,298 | 0 |
| Financing Cash Flow | $17,832 | $55,527 | $3,083 | $1,298 | $N/A |
| Beginning Cash Position | 42,565 | 887 | N/A | N/A | N/A |
| End Cash Position | 32,426 | 42,565 | 887 | N/A | N/A |
| Net Cash Flow | $-10,139 | $41,678 | $887 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,101 | -13,509 | -2,196 | -1,294 | N/A |
| Capital Expenditure | -870 | -340 | N/A | -4 | N/A |
| Free Cash Flow | -27,971 | -13,849 | -2,196 | -1,298 | 0 |